Automation / robotics

Welcome to the Future of Drug Discovery. Welcome to Arctoris from Arctoris on Vimeo. Arctoris is a global platform company headquartered in Oxford, UK that is transforming drug discovery by combining robotics and AI. Arctoris developed and operates Ulysses, a fully automated drug discovery platform. Ulysses has been created to address fundamental problems with conventional […]

Scientific and technological advancements continue to emphasise the importance of automation, both in the physical and digital world. Given recent discussions about the lab of the future, the benefits have expanded to highlight how automation can support greater connectivity between data and workflows, paving the way to a ‘smarter lab’. Thermo Fisher Scientific believes a […]

SPT Labtech, a global player in the design and development of automated instrumentation and consumables for life science applications, has acquired BioMicroLab, a robotics automation provider for life science laboratories. Headquartered in Northern California, BioMicroLab designs and manufactures laboratory automation equipment for biotechnology and scientific research. BioMicroLab’s extensive range of sample handling and tracking solutions […]

SPT Labtech, a global player in the design and development of automated instrumentation and consumables for life science applications, has announced the acquisition of Apricot Designs, California. Apricot Designs has established a 30-year track record supporting increasingly complex and evolving laboratory research requirements with the design and manufacture of multichannel micro-volume pipettors and sample preparation […]

Automating workflows allows labs to do more with less says PerkinElmer who will be at SLAS2021 on booth 33. Laboratories face many challenges today which are leading them to automate and miniaturise their workflows to alleviate these challenges. PerkinElmer has range of solutions including automating entire workflows based on needs and space requirements; scalable and […]

By Dr Karin Bottcher High content screening (HCS) has played a significant role in infectious disease research and drug discovery to date and can be a strong tool in the age of COVID-19 and beyond. With a focus on viral diseases, this article will describe how HCS has been used by laboratories around the world […]

The COVID-19 antiviral race: we’re all in this together By Uduak Grace Thomas In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically effective antiviral. The aptly named […]

By Richard Gray The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new. Microfluidics technologies can be used to accelerate the vaccine development process in a number of ways, not least in the directed evolution of the strains […]

The CELL CULTURE innovations increasing drug discovery success By Helen Stewart-Miller and Abby George Volume 21 Issue 3 – Summer 2020 ‘Fail early, fail fast’ has been a mantra in the pharmaceutical industry for several years and directly impacts the overall strategy of many drug discovery and development programmes. Yet, despite the drive to fail […]

Unleashing High-Throughput Reaction Screening The Unchained way Sponsored by Unchained Labs A successful high-throughput approach to reaction screening requires rational and systematic exploration of a broad set of variables to achieve optimization expeditiously. There are many types of potential variables that can be screened. Even with the aid of high-throughput screening tools, chances are that […]